Anzeige
Mehr »
Login
Donnerstag, 23.01.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N85T ISIN: US7611235042 Ticker-Symbol: N/A 
Frankfurt
12.04.19
09:15 Uhr
0,135 Euro
0,000
0,00 %
1-Jahres-Chart
RESHAPE LIFESCIENCES INC Chart 1 Jahr
5-Tage-Chart
RESHAPE LIFESCIENCES INC 5-Tage-Chart

Aktuelle News zur RESHAPE LIFESCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.11.19ReShape Lifesciences' (RSLS) CEO Bart Bandy on Q3 2019 Results - Earnings Call Transcript6
RESHAPE LIFESCIENCES Aktie jetzt für 4€ handeln
14.11.19ReShape Lifesciences Inc.: ReShape Lifesciences Announces Third Quarter 2019 Financial Results304SAN CLEMENTE, CA / ACCESSWIRE / November 14, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases...
► Artikel lesen
11.11.19ReShape Lifesciences Inc.: ReShape Lifesciences Announces 1-for-120 Reverse Stock Split538SAN CLEMENTE, CA / ACCESSWIRE / November 11, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced...
► Artikel lesen
07.11.19ReShape Lifesciences Inc.: ReShape Lifesciences to Host Third Quarter 2019 Conference Call on November 14, 2019291SAN CLEMENTE, CA / ACCESSWIRE / November 7, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases...
► Artikel lesen
05.11.19ReShape Lifesciences Inc.: ReShape Lifesciences Announces Strategic Marketing Partnership for LAP-BAND(R)236SAN CLEMENTE, CA / ACCESSWIRE / November 5, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases...
► Artikel lesen
30.10.19ReShape Lifesciences Inc.: ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer214SAN CLEMENTE, CA / ACCESSWIRE / October 30, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases...
► Artikel lesen
24.10.19ReShape Lifesciences Inc. - 8-K, Current Report-
17.10.19ReShape Lifesciences Inc.: ReShape Lifesciences Announces Attendance and Presentation at Obesity Week 2019327SAN CLEMENTE, CA / ACCESSWIRE / October 17, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases...
► Artikel lesen
30.09.19ReShape Lifesciences Inc. - 8-K, Current Report1
23.09.19ReShape Lifesciences Inc.: ReShape Lifesciences Enters into Early Warrant Exercise Transaction and Receives an Additional $7.65 Million in Proceeds297SAN CLEMENTE, CA / ACCESSWIRE / September 23, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today entered...
► Artikel lesen
03.09.19ReShape Lifesciences Inc.: ReShape Lifesciences to Participate in the H. C. Wainwright Global Investment Conference248SAN CLEMENTE, CA / ACCESSWIRE / September 3, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today...
► Artikel lesen
22.08.19ReShape Lifesciences Inc.: ReShape Lifesciences to Highlight Products at IFSO 24th World Congress294SAN CLEMENTE, CA / ACCESSWIRE / August 22, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that...
► Artikel lesen
19.08.19ReShape Lifesciences Inc. - 10-Q, Quaterly Report1
15.08.19ReShape Lifesciences Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB1
14.08.19ReShape Lifesciences Inc.: ReShape Lifesciences Announces Second Quarter 2019 Financial Results300San Clemente, CA / ACCESSWIRE / August 14, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today reported financial...
► Artikel lesen
09.08.19ReShape Lifesciences Inc.: ReShape Lifesciences to Host Second Quarter 2019 Conference Call on August 14, 201990SAN CLEMENTE, CA / ACCESSWIRE / August 8, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that...
► Artikel lesen
06.08.19ReShape Lifesciences Inc.: ReShape Lifesciences Announces CFO Resignation130SAN CLEMENTE, CA / ACCESSWIRE / August 6, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today Scott...
► Artikel lesen
18.06.19ReShape Lifesciences Inc.: ReShape Lifesciences to Highlight LAP-Band Weight Loss Technology at ASMBS Spring Meeting123SAN CLEMENTE, CA / ACCESSWIRE / June 18, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that...
► Artikel lesen
14.06.19ReShape Lifesciences Inc.: ReShape Lifesciences Announces $8 Million Private Placement94SAN CLEMENTE, CA / ACCESSWIRE / June 14, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that...
► Artikel lesen
04.06.19ReShape Lifesciences Inc.: ReShape Lifesciences Strengthens Executive Leadership Team with Appointment of Kevin Condrin as Senior Vice President of Commercial92SAN CLEMENTE, CA / ACCESSWIRE / June 4, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today the...
► Artikel lesen
Seite:  Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1